Article Details
Retrieved on: 2021-02-23 10:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Neo Ivy Capital Management now owns 1,824 shares of the biopharmaceutical company's stock valued at $76,000 after acquiring an additional 722 ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here